Jodi Knapp

How does Parkinson’s prevalence differ in twin studies, what proportion of identical twins develop the disease, and how do their risks compare with fraternal twins?

🌏 A Traveler’s Reflection on Two Paths from the Same Village

My name is Prakob Panmanee, but my life for the past thirty years has been lived under the name “Mr. Hotsia.” It has been a solo journey, a deep immersion into the lifeblood of Southeast Asia. I have walked the soil of every province in my native Thailand, followed the Mekong into Laos and Cambodia, navigated the bustling streets of Vietnam, and sat with elders in the quiet, timeless villages of Myanmar. My first career was in systems analysis, a world that taught me to look for the underlying code, the fundamental blueprint that governs any complex system.

I carry a memory from a small Karen village in the mountains near the Thai-Myanmar border. In this village lived a pair of identical twin boys, perhaps seven or eight years old. To a stranger’s eye, they were indistinguishable—the same mischievous smile, the same way of running, the same laugh. The villagers often spoke of them as one. But their mother, with a knowing smile, could tell them apart from across the village. She knew one was bolder, the other more cautious. One loved spicy food, the other did not. They were forged from the same blueprint, yet their experiences were already etching unique stories upon them.

This image has often returned to me when I think about health and destiny. We are all born with a genetic blueprint, a set of instructions inherited from our ancestors. For a long time, we have viewed diseases like Parkinson’s as a cruel fate written into that code. But what if that’s not the whole story? What if the code is just the starting point, and the journey of life itself is the true author of our health? To answer this question, science has a perfect natural experiment, a way to untangle the threads of nature and nurture: the study of twins.

🤔 The Blueprint and the Journey: Deconstructing Parkinson’s

From my systems analysis background, I learned to ask a simple question when a system fails: is it a hardware problem or a software problem? In human terms, this is the age-old debate of nature versus nurture. Is Parkinson’s disease a “hardware” issue—a predetermined flaw in our genetic code? Or is it a “software” issue—the result of a lifetime of environmental inputs, lifestyle choices, and random chance?

For a long time, the answer was a mystery. Parkinson’s doesn’t typically run in families in a clear, predictable way like some other inherited diseases. This led many to believe genetics played only a minor role. To solve this puzzle, researchers turned to the most powerful tool for studying heredity: twins.

• Identical (Monozygotic) Twins: These twins come from a single fertilized egg that splits in two. They are nature’s clones, sharing 100% of their genetic material. If a disease is purely genetic, they provide the ultimate test. If one has it, the other should too.
• Fraternal (Dizygotic) Twins: These twins come from two separate eggs fertilized at the same time. Genetically, they are no more similar than any other pair of siblings, sharing about 50% of their genes. They serve as a perfect comparison group.

By studying these two types of twins, researchers can isolate the influence of genes. The question they ask is simple: When one twin gets Parkinson’s, what are the chances the other one will too? This is called the “concordance rate,” and its answer has fundamentally changed our understanding of the disease.

🧬 The Startling Revelation: What the Numbers Tell Us

The results from decades of twin studies have been both surprising and incredibly empowering. If Parkinson’s were a purely genetic disease, like Huntington’s disease, the concordance rate for identical twins would be nearly 100%. The genetic blueprint would be an unavoidable destiny.

But that is not what the studies found. Not even close.

When researchers looked at large populations of twins, they discovered that the concordance rate for identical twins—two people with the exact same DNA—was remarkably low. On average, if one identical twin develops Parkinson’s, the chance of the other twin also developing the disease is only about 10% to 15%.

Let that sink in. In roughly 85-90% of cases, when one identical twin is diagnosed with Parkinson’s disease, their genetic double, their perfect clone, never gets it.

This single finding is a bombshell. It tells us, unequivocally, that for the vast majority of people, genes are not the sole cause of Parkinson’s. The blueprint is not the story. Something else is at play. The journey of life—the environment, the exposures, the unique path each twin walks after they are born—must be the deciding factor. The concordance rate for fraternal twins is even lower, hovering around 2-5%, which is about the same as any non-twin sibling, further reinforcing that shared DNA is not the primary driver.

⚖️ A Tale of Two Twins: A Direct Comparison of Risk

To truly grasp the meaning of these findings, it’s helpful to see the two groups side-by-side. The differences are not just in the numbers, but in what those numbers tell us about the nature of the disease.

🧩 The “Gun and Trigger” – The Modern Understanding

So, if genes are not the full story, what is? The modern understanding of Parkinson’s is often explained with the “gun and trigger” analogy.

For most people, genetics may “load the gun.” That is, some individuals are born with a combination of genes that gives them a slightly higher susceptibility to the disease. Their neurological system may be a bit more vulnerable. But the gun, even when loaded, is harmless until something pulls the trigger.

The “trigger” is the environment. This includes a lifetime of exposures to factors that we are now certain can initiate or accelerate the neurodegenerative process. These triggers include:

• Pesticides and Herbicides
• Industrial Solvents like Trichloroethylene (TCE)
• Head Trauma
• Certain Infections

This explains the twin studies perfectly. Two identical twins are born with the same “loaded gun.” But one may become a farmer and be exposed to pesticides for 30 years, while the other becomes an accountant in the city. One may suffer a serious head injury, while the other does not. Their unique life journeys present them with different triggers. And so, one develops Parkinson’s, and the other does not.

It is important to note that there is a small subset of Parkinson’s cases, particularly those with a very early age of onset (under 50), where genetics do play a much more direct and powerful role. In these rare cases, a single, potent gene mutation can be the primary cause. And indeed, twin studies show a higher concordance rate for this early-onset group, confirming that this is a different, more purely genetic form of the disease.

🌿 Final Reflections from the Road

My travels have taught me to be skeptical of simple answers to complex questions. The health of a village is never due to one thing; it’s the interplay of the clean water, the fertile soil, the strong community, and the knowledge passed down through generations. The story of Parkinson’s is the same. It is not a simple story of bad genes. It is a complex interplay between the blueprint we are born with and the world we inhabit.

This is, in the end, a profoundly hopeful message. It is a shift away from genetic fatalism and towards empowerment. We cannot change the genes we inherit from our parents. But we can, as individuals and as a society, make choices about the environment we create. We can advocate for safer agricultural practices, for stricter controls on industrial pollutants, and for better protection against the known triggers of this disease.

The two twin boys in that Karen village will walk two different paths in life. They started from the same point, but their journeys will be their own. The same is true for all of us. Our genetic blueprint is the village we are born in, but the map of our life is one we help to draw every single day.

Frequently Asked questions (FAQ)

1. If my identical twin has Parkinson’s, what should I do? First, remember that your chance of remaining disease-free is very high (85-90%). This is an opportunity to be proactive. Focus on a healthy lifestyle with regular exercise and a balanced diet. Most importantly, be vigilant about reducing your exposure to known environmental risk factors like pesticides and industrial solvents.

2. Should I get genetic testing for Parkinson’s? For the vast majority of people, genetic testing for Parkinson’s is not recommended. The most common genes associated with the disease only slightly increase the risk and are not predictive. Testing is typically only considered for people with a very strong family history or a very early age of onset, and it should always be done with the guidance of a genetic counselor.

3. Does this mean that Parkinson’s is preventable? While there is no guaranteed way to prevent Parkinson’s, these findings strongly suggest that we can significantly reduce our risk. The most powerful known preventative measure is regular, vigorous exercise. Beyond that, avoiding head injuries and minimizing exposure to pesticides and other toxic chemicals are crucial, practical steps.

4. What if Parkinson’s runs in my family, but we are not twins? Having a first-degree relative (parent or sibling) with Parkinson’s does slightly increase your risk, typically by about two to three times the average. While this sounds like a lot, the absolute risk is still very low for most people. The “gun and trigger” model still applies—your family may share a genetic susceptibility, making environmental awareness even more important.

5. Have specific genes been identified that cause Parkinson’s? Yes. In a small number of families with a very strong history of the disease, specific gene mutations (in genes like SNCA, LRRK2, Parkin) have been identified that can directly cause Parkinson’s. These are the rare, “hardware-dominant” cases and are not representative of the more than 90% of cases that are considered “sporadic.”

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. Learn more